SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Genesys (CEGE)
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
1298 85 0 CEGE
Emcee:  Bharat Kalra Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1148Thanks, Collin and Jason, here's the abstract. In my experience, <i>Cscaram(o)uche-9/9/2001
1147Since links to news releases expire, here is the release <i> Thursday Septtnsaf-9/6/2001
1146Cell Genesys Reports Positive Preclinical Studies of CV890 for Liver Cancer bizSnowShredder-9/6/2001
1145Cell Genesys Completes Acquisition of Calydon biz.yahoo.comSemiBull-9/5/2001
1144Cell Genesys Appoints Peter Working Vice President of Research and Development bSemiBull-8/29/2001
1143Strong Buy initiated on Cell Genesys by Ladenburg Thalmann biz.yahoo.comSemiBull-8/22/2001
1142Cell Genesys Promotes Joseph Vallner to President biz.yahoo.comSemiBull-8/22/2001
1141>>FOSTER CITY, Calif. and SAN DIEGO, Aug. 10 /PRNewswire/ -- Cell Genesys,tuck-8/10/2001
1140Cell Genesys and GPC Biotech Report Positive Preclinical Results For Cardiovascunigel bates-8/6/2001
1139Interesting CC Cell Genesys, Inc. Invites You to Listen to Conference Call biz.SemiBull-8/2/2001
1138Nice, I've been wondering when Calydon would enter into the public domain. SnowShredder-8/2/2001
1137A small munch for CEGE: >>FOSTER CITY, Calif., Aug. 2 /PRNewswire/ -- Celtuck-8/2/2001
1136Cell Genesys Reports Second Quarter Results - Ends Quarter With $232 Million in SemiBull-7/23/2001
1135Cell Genesys Initiates Second Multicenter Phase I/II Trial of GVAX(R) Lung CanceSemiBull-6/21/2001
1134This might help, but there is already competition here (from GNT, for example): tuck-6/19/2001
1133webcast of cege annual shareholder meeting available at the company website throMadharry-6/8/2001
1132Cell Genesys GVAX(R) Lung Cancer Vaccine Clinical Data Chosen to Be Highlighted SemiBull-6/1/2001
1131ASGT results from ENMD collaboration: >>SEATTLE, June 1 /PRNewswire/ -- Ctuck-6/1/2001
1130I think that your methodology is a good starting point but we have to adjust forMadharry-5/20/2001
1129Londo Thanks for your opinions. It is of course possible to do this type of &quIcebrg-5/20/2001
1128One can make the argument that the $200-$400M valuation has already been reachedLondo-5/20/2001
1127Tuck--I don't know if this has been posted but Business Week (5/28/01) in iJOEBT1-5/20/2001
1126Madharry My guess would be somewhere between 200 and 400 mUSD. CEGEs current maIcebrg-5/20/2001
1125Looks like CEGE continues to sell for the value of cash and shares of ABGX. How Madharry-5/20/2001
1124Oops. (eom)nigel bates-5/17/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News